Skip to search formSkip to main contentSkip to account menu

lonaprisan

Known as: 11 beta-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17 alpha-pregna-5,9-dien-3-one, 11-(4-acetylphenyl)-17-hydroxy-17-(1,1,2,2,2-pentafluoroethyl)estra-4,9-dien-3-one 
An orally bioavailable pentafluoroethyl derivative of a mifepristone-related steroid with antiprogestagenic activity. Lonaprisan is a pure, highly… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Estrenes

Narrower (1)

ZK 230211

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
W. Jonat1*, T. Bachelot2, T. Ruhstaller3, I. Kuss4, U. Reimann4 & J. F. R. Robertson5 Department of Gynaecology and Obstetrics… 
2011
2011
The anti-tumourigenic action of the progesterone receptor antagonist Lonaprisan (ZK230211) in breast cancer
2010
2010
Neue Entwicklungen in der endokrinen Therapie des prämenopausalen Mammakarzinoms
ZusammenfassungDie Empfehlungen zur endokrinen Therapie der prämenopausalen Mammakarzinompatientin sind seit Jahren unverändert… 
2009
2009
Endokrine Therapie des Mammakarzinoms
ZusammenfassungDie systemische endokrine Therapie des hormonrezeptorpositiven Mammakarzinoms hat sich in den letzten 10 Jahren… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)